# The Role of the Kidneys and Liver in the Elimination of Glucagon

> **NCT05056584** · NA · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 48 (actual)

## Conditions studied

- Chronic Kidney Diseases
- Liver Cirrhosis
- Hyperglucagonemia

## Interventions

- **BIOLOGICAL:** Glucagon infusion
- **BIOLOGICAL:** Primed tracer infusion

## Key facts

- **NCT ID:** NCT05056584
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-01
- **Primary completion:** 2023-03-28
- **Final completion:** 2023-03-28
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2023-05-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05056584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05056584, "The Role of the Kidneys and Liver in the Elimination of Glucagon". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT05056584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*